Acute Effect of the Thoraco-abdominal Rebalance Method Postoperative Cardiac Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35+
SponsorInstituto de Cardiologia do Rio Grande do Sul

About this trial

Introduction: The thoracoabdominal rebalancing (TAR) method aims to promote diaphragmatic juxtaposition, in addition to seeking to increase respiratory muscle strength and adjust muscle tone. However, scientific publications on this method in heart patients undergoing coronary artery bypass grafting (CABG) are still scarce, justifying the need to carry out this study for information, evaluation, diagnosis and treatment purposes in the health area with an emphasis on cardiology.

Objective: To evaluate whether diaphragmatic ultrasound findings differ between the TAR method and conventional physiotherapy in post-CABG patients.

Methods: This is a randomized, single-blind clinical trial. Adults (\>35 years), hemodynamically stable, who underwent CABG (\<24 hours) and had a prescription for physiotherapy will be included. Patients will be randomized into two groups: 1) intervention group \[IG\] - TAR; 2) control group \[CG\] - standard physiotherapy approach. Interventions will be performed at a single time and the following variables will be collected pre- and post-intervention: heart rate (HR), respiratory rate (RR), peripheral oxygen saturation (SpO2), mean arterial pressure (MAP), diaphragmatic ultrasound (US) to identify possible acute findings in both groups, respiratory distress scale and pulmonary complications scale will be applied at the end of the interventions.

Keywords: Physiotherapy; Cardiology; Ultrasonography

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals over 35 years of age who undergo coronary artery bypass graft surgery with prescribed physiotherapy treatment will be included in the study.

Disqualifiers

Patients who are intubated and/or have remained on mechanical ventilation for more than twelve hours, or who require non-invasive mechanical ventilation (NIV) before or during the collection period will be excluded.

Trial design

Design model

Sequential

Treatments tested in this trial

  • TAR Method

    Procedure/Surgery

    Patients selected for the intervention group will undergo thoracoabdominal rebalancing management such as abdominal supports and/or in the ileocostal space, inspiratory assistance, release of the shoulder girdle, thoracic balance, release of the pectoralis major and deltoid muscles together with aspiration if necessary.

  • Conventional physiotherapy

    Procedure/Surgery

    Patients selected for the control group (conventional physiotherapy) will be exposed to respiratory physiotherapy techniques such as vibrocompression, manual passive expiratory therapy, acceleration of expiratory flow, fractional inspiration in times, diaphragmatic breaths and aspiration when necessary.

Treatment groups

26 Participants
are divided into 2 treatment groups
Group A: Conventional physiotherapyActive comparator 1 intervention
Group B: TAR MethodActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Diaphragmatic excursion

Increase in measures

Time frame
Immediately before the intervention and within 30 minutes after the intervention
2

Change in the Downes and Raphaelly respiratory distress scale

Points 0-10, where 0 is best and 10 is worst

Time frame
Immediately before the intervention and within 30 minutes after the intervention
3

Pulmonary spirometry

Increase in measurements: CVF (L)

Time frame
Immediately before the intervention and within 30 minutes after the intervention

Secondary outcomes

1

Respiratory rate

Breathing intervals per minute

Time frame
Immediately before the intervention and within 30 minutes after the intervention
2

Peripheral oxygen saturation

SpO2

Time frame
Immediately before the intervention and within 30 minutes after the intervention
3

Mean arterial pressure

mmHg

Time frame
Immediately before the intervention and within 30 minutes after the intervention
4

Lung auscultation assessment

Wheezing, rhonchi or stridor

Time frame
Immediately before the intervention and within 30 minutes after the intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.